Objective-Xanthine oxidoreductase (XOR) catalyzes the production of uric acid with concomitant generation of reactive oxygen species. XOR has been shown to regulate adipogenesis through the control of peroxisome proliferator-activated receptor γ, but its role in adipose tissue remains unclear. The aim of this study was to examine the role of XOR in adipose tissue using XOR genetically modified mice. Approach and Results-Experiments were performed using 2-, 4-, and 18-month-old XOR heterozygous mice (XOR +/− ) and their wild-type littermates to evaluate the physiological role of XOR as the mice aged. Stromal vascular fraction cells were prepared from epididymal white adipose tissue in 2-month-old XOR mice to assess adipogenesis. At 18 months, XOR +/− mice had significantly higher body weight, higher systolic blood pressure, and higher incidence of insulin resistance compared with wild-type mice. At 4 months, blood glucose and the expressions of CCAAT enhancer-binding protein β, peroxisome proliferator-activated receptor γ, monocyte chemoattractant protein-1, and tumor necrosis factor α mRNA in epididymal white adipose tissue were significantly higher in XOR +/− than in wild-type mice. Furthermore, histological analysis of epididymal white adipose tissue in XOR +/− mice revealed that adipocyte size and the F4/80-positive macrophage count were increased. Experiments with a high-fat diet exhibited that body weight gain was also significantly higher in XOR +/− than in wild-type mice. In stromal vascular fraction cells derived from XOR +/− mice, the levels of peroxisome proliferator-activated receptor γ, fatty acid-binding protein 4, and CCAAT enhancer-binding protein α mRNA were upregulated, and oxidative stress levels were elevated during differentiation into adipocytes. Conclusions-These results suggest that the reduction in XOR gene expression in mice augments lipid accumulation in adipocytes, accompanied by an increase in oxidative stress, and induces obesity with insulin resistance in older age. 
X
anthine oxidoreductase (XOR) is a key enzyme in purine catabolism, the process by which purine is converted to xanthine and uric acid. 1 It has been reported that XOR is a critical source of reactive oxygen species (ROS) and nitric oxide and also plays an important role in a variety of physiological 2 and pathophysiological conditions, such as ischemia-reperfusion injury, 3 endothelial dysfunction in diabetes mellitus, 4 and various cardiovascular diseases. [5] [6] [7] [8] [9] Furthermore, XOR is a structural component of membraneencapsulated milk fat globules, 10 and mice lacking XOR have defects in fat droplet secretion. 11 We also showed that XOR gene disruption induced the deletion of uric acid and the accumulation of triglyceride-rich substances and crystals in the renal tubules, with increased expression of adipogenesisrelated genes such as peroxisome proliferator-activated receptor (PPAR) γ and the CCAAT enhancer-binding proteins (C/ EBP) β and C/EBPα. 12 These findings suggest that XOR may be implicated in lipid metabolism and adipogenesis.
In a study on adipocyte differentiation using 3T3-L1 preadipocytes, it was reported that XOR lies downstream of C/EBPβ and upstream of PPARγ in the signaling pathway responsible for regulating adipocyte differentiation. 13 Furthermore, Hallenborg et al 14 have shown that XOR and epidermal-type lipoxygenase 3 may synergistically activate PPARγ and promote adipocyte differentiation through the activity of ROS produced by XOR. These studies using 3T3-L1 preadipocytes in vitro have suggested the possibility that decreased XOR activity may correlate with a reduction in lipid accumulation. However, the precise role of XOR in adipogenesis in vivo is not fully understood.
In this study, therefore, we used XOR heterozygous (XOR +/− ) knockout mice to investigate the role of XOR activity in adipogenesis in vivo and also analyzed the effects of aging and intake of a high-fat diet (HFD) on the phenotype of XOR +/− mice. In addition, we examined adipogenesis using adipose tissue-derived stromal vascular fraction (SVF) cells prepared from XOR +/− mice and their wild-type (WT) littermates. The SVF cells are a heterogeneous cell population that includes adipocyte progenitor cells (preadipocytes). 15, 16 Furthermore, preadipocytes in the SVF can differentiate into adipocytes by adequate hormonal stimulation. SVF cells, including macrophages and all components of adipose tissue except mature lipid-laden adipocytes, are closer to the physiological conditions of adipose tissue than 3T3-L1 cells. Thus, we used SVF cells prepared from XOR gene-disrupted mice to evaluate the role of XOR on adipogenesis in vitro.
Methods
Materials and Methods are available in the online-only Supplement.
Results

Reduction in XOR Gene Expression Facilitates an Increase in Body Weight With Aging
XOR
+/− mice at 18 months of age showed significant increases in body weight (47.1±1.4 versus 39.4±0.6 g; P<0.05), epididymal fat pad weight (2.4±0.2 versus 1.4±0.1 g; P<0.05), and liver weight compared with WT mice without alteration of food intake ( Figure 1A , 1C, and 1D and Figure I in the online-only Data Supplement). Systolic blood pressure was higher in XOR +/− mice than in WT mice (96.1±0.7 versus 90.7±0.9 mm Hg; P<0.05; Figure 1B Figure 1F-1H) , indicating obesity-associated impairment of glucose tolerance. However, the serum concentrations of cholesterol, triglyceride, and free fatty acids were not different between 18-month-old WT and XOR +/− mice ( Table I in the onlineonly Data Supplement). The serum uric acid concentrations of XOR +/− mice were approximately half those of WT mice ( Figure 1E ). Inflammation of adipose tissue is associated with obesity-related insulin resistance. To assess the inflammation in epididymal white adipose tissue (eWAT), we performed quantitative reverse transcriptase-polymerase chain reaction analysis on the eWAT. XOR +/− mice showed increases in the expression of monocyte chemoattractant protein-1 (MCP-1), tumor necrosis factor (TNF) α, and leptin mRNA and a decrease in the level of adiponectin mRNA, indicating that reduction in XOR expression caused the inflammation in eWAT ( Figure 1I ). XOR activity in eWAT at 2 and 12 months of age was 10-to 50-fold higher than in other tissues such as liver, kidney, and heart tissue ( Figure IIA and IIB in the online-only Data Supplement), which suggested that XOR may play an important role in white adipose tissue.
XOR +/− Mice at 4 Months of Age Exhibit Impaired Glucose Tolerance Without Obesity
Phenotypic analysis of XOR +/− mice at 4 months of age showed that there were no differences in body weight and heart, kidney, and liver tissue weights, but the amount of eWAT was significantly greater in XOR +/− mice than in WT mice (Figure 2A  and 2B with WT mice (Figure 2C-2E ). Systolic blood pressure was increased, and endothelial-dependent relaxation was attenuated in XOR +/− mice compared with WT mice (Figure 3 ). Serum concentrations of lipids were not different between XOR +/− and WT mice (Table I in the online-only Data Supplement). In addition, the expressions of C/EBPβ, PPARγ, fatty acidbinding protein 4 (FABP4), fat-specific protein 27, leptin, nicotinamide adenine dinucleotide phosphate oxidase 4 (Nox4), MCP-1, and TNFα mRNA were significantly increased in the eWAT of XOR +/− mice ( Figure 2H) . The oxidative stress level evaluated by the production of malondialdehyde and H 2 O 2 in eWAT was also elevated in XOR +/− mice compared with WT mice ( Figure 2F and 2G).
To assess the histological change, sections of eWAT were stained with hematoxylin and eosin. Enlarged adipocytes were found in XOR +/− mice compared with WT mice, and the average value of the adipocyte area was significantly greater in XOR +/− mice (3.45±0.04 versus 2.94±0.04 μm 2 ×10 3 ; Figure 4A ). Enlargement of the adipocytes releases higher amounts of proinflammatory mediators such as leptin and lower amounts of adiponectin. To quantify macrophage infiltration in the eWAT, immunohistochemical staining using the macrophage-specific marker F4/80 was performed. The percentage of F4/80-positive macrophages in XOR +/− mice was increased 5-fold compared with WT mice. Crown-like structures, which were associated with dead adipocytes surrounded by macrophages, were observed only in the eWAT of XOR +/− mice ( Figure 4B ).
High-Fat Diet Facilitates an Increase in Body Weight of XOR +/− Mice Compared With WT Mice
To investigate the influence of the XOR genotype on HFDinduced obesity, WT and XOR +/− mice at 2 months of age were fed a normal diet or HFD for 2 or 10 weeks. Body weight gain was similar for the 2 normal diet mouse groups, but between the 2 HFD groups, it was significantly increased in XOR +/− mice compared with the WT mice (45.9±0.7 versus 40.7±0.8 g; P<0.05; Figure 5A ) without alteration of food intake ( Figure III in the online-only Data Supplement). There were no differences in body or liver weight after 2 weeks with an HFD, but the amount of eWAT was significantly greater in XOR +/− HFD mice than in WT HFD mice ( Figure 5B ). Glucose tolerance evaluated by intraperitoneal glucose tolerance test was impaired, and fasting serum insulin levels (3.3±0. in the expression of MCP-1, TNFα, and leptin mRNA and a decrease in the level of adiponectin mRNA ( Figure 5F ). In addition, enlarged adipocytes were detected in XOR +/− HFD mice compared with WT HFD mice, and the average value of the adipocyte area was significantly greater in XOR +/− HFD mice (6.51±0.11 versus 6.11±0.11 μm 2 ×10 3 ; P<0.05; Figure  5G ). These results suggest that XOR +/− mice facilitate obesity and insulin resistance by upregulation of fat accumulation in mature adipocytes.
SVF Cells Derived From eWAT in XOR +/− Mice Facilitate Adipocyte Differentiation
At 2 months of age, there were no differences in the body weight or eWAT weight between WT and XOR +/− mice. Insulin sensitivity indices, such as the glucose tolerance test, fasting insulin level, and homeostasis model assessment of insulin resistance, in XOR +/− mice were not different from those in WT mice ( Figure 6A-6E) . Furthermore, the mRNA expressions of the inflammation-related proteins MCP-1 and TNFα in the eWAT were not different between WT and XOR +/− mice, but the mRNA levels of adipocyte differentiation-related proteins such as C/EBPβ, PPARγ, and FABP4 were significantly higher in the eWAT of XOR +/− mice ( Figure 6F ). The production of H 2 O 2 was significantly higher in XOR +/− mice, but the amount of malondialdehyde was not significantly different between the 2 groups ( Figure 6G and  6H) . We prepared SVF cells from these 2-month-old mice and evaluated their adipocyte differentiation. The SVF cells were differentiated into adipocytes, and accumulated lipids were stained with oil red O on day 7. Lipid accumulation in the differentiated SVF cells was much greater in XOR +/− mice than in WT mice ( Figure 7A ). The levels of PPARγ, FABP4, and C/EBPα mRNA, which normally increase during adipogenesis, were significantly increased in XOR +/− mice during adipocyte differentiation ( Figure 7B) . Interestingly, the expression of C/EBPβ mRNA was not induced by the stimulation of adipocyte differentiation, but it was significantly higher in XOR +/− mice than in WT mice during differentiation, suggesting that XOR +/− mice have sustained higher expression levels of C/EBPβ in adipose tissue. The SVF cells derived from XOR +/− mice showed a higher rate of H 2 O 2 production compared with those from WT mice during differentiation ( Figure 7C ). Furthermore, the superoxide level was also significantly increased in XOR +/− mice compared with WT mice by nitroblue tetrazolium reduction assay ( Figure 7D ). To elucidate the source of ROS production, we examined 3 major pathways of ROS production, namely the XOR-, Nox4-and mitochondria-mediated pathways in the differentiated SVF cells. ROS production in differentiated SVF cells was not suppressed by oxypurinol, an inhibitor of XOR, or by rotenone, an inhibitor of mitochondrial electron transport chain complex I, but was suppressed by apocynin, an inhibitor of nicotinamide adenine dinucleotide phosphate oxidase ( Figure 7E ). In addition, the expression level of Nox4 mRNA was significantly higher in XOR +/− mice, but the mRNA expression levels of other Nox subunits in XOR +/− mice were not significantly different from those in WT mice ( Figure 7B and Figure IV in the online-only Data Supplement). These results suggest that Nox4 is the major source of ROS in differentiated SVF cells and that the SVF cells derived from XOR +/− mice facilitate lipid accumulation in adipocytes exposed to higher oxidative stress during differentiation.
Discussion
In the present study, XOR +/− mice exhibited significantly increased body weight with aging and also showed higher rates of insulin resistance and higher blood pressure levels compared with WT mice. An HFD also induced significant gains in body weight and eWAT weight in XOR +/− mice compared with WT mice. The body weight in XOR +/− mice at 4 months of age was not different from that in WT mice; however, the eWAT in XOR +/− mice exhibited inflammation with macrophage infiltration and accumulated lipids with adipocyte hypertrophy. Furthermore, 4-month-old XOR +/− mice had higher incidence of insulin resistance and higher blood pressure levels compared with WT mice. XOR +/− mice at 2 months of age did not have inflammatory change, insulin resistance, or an increase in blood pressure but had higher expression levels of C/EBPβ, PPARγ, and FABP4 mRNA than in WT mice. In addition, the expression of C/EBPβ mRNA in SVF cells derived from XOR +/− mice was not increased by the stimulation of adipocyte differentiation, but the level of this expression remained higher than in WT mice during differentiation. Reactive oxygen species (ROS) production from SVF cells during differentiation into adipocytes. ROS production was measured by nitroblue tetrazolium reduction, n=8 per group. Dark blue formazan was dissolved, and the absorbance was determined at 560 nm (D). Effect of inhibitors of ROS production in SVF cells at day 7 after differentiation. At 1 hour before finishing the incubation, 200 μmol/L apocynin, 100 μmol/L oxypurinol, or 100 μmol/L rotenone was added, and ROS production was measured by nitroblue tetrazolium reduction (E). *P<0.05 compared with WT. †P<0.05 compared with control. Apo indicates apocynin; C/EBP, CCAAT, enhancer-binding protein; Con, control; FABP4, fatty acid-binding protein 4; Nox4, nicotinamide adenine dinucleotide phosphate oxidase 4; Oxy, oxypurinol; PPAR, peroxisome proliferator-activated receptor; and Rot, rotenone.
These findings suggested that haploinsufficiency of XOR mice might induce sustained higher expression of C/EBPβ, adipocyte differentiation with exaggerated ROS production, and eventually obesity with insulin resistance in older age. XOR +/− mice at 18 months of age showed obesity with an increase in the expression of MCP-1 mRNA in eWAT. In contrast, the level of adiponectin mRNA was decreased, and oxidative stress levels were upregulated in eWAT. These changes contribute substantially to obesity-related low-grade inflammation in eWAT. The fat accumulation in adipose tissue is associated with not only adipocyte hypertrophy but also an increase in the number of adipocytes. An increase in small adipocytes by adipogenesis usually improves insulin resistance through the production of adiponectin and leptin, whereas hypertrophy of adipocytes exacerbates insulin resistance. 17 TNFα has been observed in the adipose tissue of obese mice with macrophage infiltration 18, 19 and has been shown to induce insulin resistance by phosphorylation of the serine residue of insulin receptor substrate-1. 20 It has been reported that ROS production was markedly increased during differentiation of 3T3-L1 preadipocytes into adipocytes and in parallel with fat accumulation in adipocytes. 21 In particular, regulated H 2 O 2 production is an essential component of insulin signaling in adipose tissue. 17, 22, 23 In this study, the SVF cells derived from XOR +/− mice exhibited higher levels of Nox4 expression and H 2 O 2 production compared with those in WT mice during differentiation. XOR +/− mice at 4 months of age showed endothelial dysfunction in the aorta and an increase in systolic blood pressure and insulin resistance with no difference in body weight compared with WT mice. These mice had increases in adipose tissue weight, MCP-1, and TNFα mRNA levels and H 2 O 2 in eWAT. Histological analysis revealed that eWAT of XOR +/− mice at 4 months of age exhibited a dramatic increase in F4/80-stained macrophage infiltration and an expansion of adipocyte size. These results suggest that the reduction in XOR gene expression exaggerated macrophage infiltration, TNFα expression, and H 2 O 2 production, resulting in continuous low-grade inflammation and finally obesity with insulin resistance.
Obesity is characterized by increases in the number and size of adipocyte cells and the profound accumulation of triglycerides in adipose tissue. Fat accumulation is induced by an increase in energy intake or a decrease in energy consumption. 24, 25 In XOR +/− mice, the amounts of daily food intake and the levels of serum lipids were not different from those in WT mice, but the size of adipocytes was larger and their differentiation was faster than in WT mice. C/EBPβ is induced in the early phase of adipocyte terminal differentiation and lies upstream of PPARγ and C/EBPα in the cascade of adipogenesis. Activation of C/EBPβ induces transcription of both PPARγ and C/EBPα, which in turn coordinately activate metabolic genes such as leptin, FABP4, and adiponectin. In this study, C/EBPβ mRNA in the differentiated SVF cells showed a sustained higher expression in XOR +/− mice than in WT mice from day 0 to day 7, suggesting that a reduction in the XOR gene might consistently increase the expression of C/ EBPβ mRNA and then induce the cascade of terminal adipocyte differentiation. In fact, there were no differences in body weight or eWAT weight, insulin sensitivity, or inflammationrelated mRNA levels between the WT and XOR +/− mice at 2 months of age, but the mRNA expressions of adipocyte differentiation-related proteins, such as C/EBPβ, PPARγ, and FABP4, were significantly increased in XOR +/− mice compared with WT mice.
Recently, Chen et al 26 reported that the amounts of plasma ceramide and spermidine in allopurinol-treated WT mice were the same as those in WT mice, although both compounds were significantly increased in the plasma of XOR −/− and XOR +/− mice. This result suggests that these 2 metabolites were not affected by XOR activity but by XOR gene expression. Ceramide and spermidine have been shown to be associated with fat accumulation. 27, 28 In addition, it has been reported that ceramide markedly induces the expression of C/EBPβ protein 29 and that spermidine promotes C/EBPβ translation. 30 Although we did not measure the plasma levels of ceramide and spermidine in the present study, these previous findings may support the idea that XOR influences the expression of C/EBPβ and regulates adipocyte differentiation through these metabolites. The SVF cells derived from XOR +/− mice facilitated fat accumulation with higher oxidative stress. The expressions of PPARγ, FABP4, and C/EBPα mRNA were significantly increased in XOR +/− mice during differentiation. These results explain why the SVF cells prepared from XOR +/− mice showed enhanced adipocyte differentiation. In contrast, previous studies using 3T3-L1 cells or mouse embryonic fibroblasts have shown that the XOR gene increased PPARγ activity and adipocyte differentiation. 13, 14 It is difficult to account for the conflicting results between the present and previous studies. However, the divergence may be related to the experimental design, that is, previous studies used cells in which XOR gene expression was transiently inhibited, but we used haploinsufficient XOR mice that showed chronic inhibition of XOR gene expression from birth. These findings may suggest that transient inhibition of the XOR gene in 3T3-L1 cells inhibits PPARγ activity and adipocyte differentiation, but chronic inhibition of the XOR gene accumulates plasma metabolites, such as ceramide and spermidine, and induces the sustained C/EBPβ expression, oxidative stress, and activation of PPARγ, probably because of an indirect effect of XOR expression in adipose tissue. Furthermore, it has been shown that the adipogenesis of adipogenic cell lines depends on an interplay among adipocyte precursors, vascular cells, and stromal cells. 31 In addition, 3T3-L1 cells express the adipocyte-secreted factor leptin at much lower levels than primary adipocytes. White adipocytes comprise a single large droplet, but 3T3-L1 cells store triglycerides in many droplets. 32 These results suggest that mouse cell lines may not reflect true adipocyte differentiation and real lipid metabolism in vivo.
XOR is a structural component of membrane-encapsulated milk fat globules and is necessary for milk fat droplet envelopment and secretion. 10 The proteins belonging to the cell death-inducing DFF45-like effector family have been shown to associate with lipid droplets. Recently, Wang et al 33 reported that Cidea, a cell death-inducing DFF45-like effector family protein, is expressed at high levels in lactating mammary glands, induces XOR expression by facilitating the association of C/EBPβ with the promoter of the XDH gene, and enhances lipid secretion in vivo. Furthermore, the fat-specific protein 27 (also called Cidec), another cell death-inducing DFF45-like effector family protein, interacts with C/EBPβ to regulate the expression of XOR in adipocytes. 33 In this study, the expression levels of both C/ EBPβ and fat-specific protein 27 mRNA in eWAT were significantly higher in 4-month-old XOR +/− mice than in WT mice of the same age. Different fat secretion mechanisms are at work in mammary epithelial cells and adipocytes; however, both the previous and present findings may indicate that XOR plays a pivotal role in adipocytes to regulate fat accumulation.
In conclusion, a reduction in XOR gene expression in mice induced fat accumulation and led to obesity with aging through increases in ROS, macrophage infiltration, and insulin resistance. Our study demonstrates that one of the roles of the XOR gene may regulate fat metabolism via C/EBPβ expression.
